Viewing Study NCT04963595


Ignite Creation Date: 2025-12-24 @ 2:17 PM
Ignite Modification Date: 2026-02-23 @ 4:31 AM
Study NCT ID: NCT04963595
Status: UNKNOWN
Last Update Posted: 2021-07-15
First Post: 2021-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer
Sponsor: Zhiyong Yu
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module